---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-012213"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2025-02-11T23:59:59+00:00"
generated_at: "2026-05-26T23:31:04.967369+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Denali Capital Acquisition Corp. Extends Business Combination Deadline to March 11, 2025

## Summary
- Deposited $15,036.74 into trust account to extend deadline for completing a business combination by one month.
- Extension moves deadline from February 11, 2025 to March 11, 2025.
- Funding from a convertible promissory note issued to Scilex Holding Company (SCLX) with a principal amount of up to $180,000.
- Note is non-interest bearing, repayable upon business combination or liquidation, and convertible into Class A ordinary shares at $10.00 per share at Scilex's option.

## SEC filing metadata
- accession: 0001213900-25-012213
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2025-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390025012213/0001213900-25-012213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390025012213/ea023067101-8k425_denalicap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-012213
- JSON: https://secwatch.observer/filing/0001213900-25-012213.json
- Plain text: https://secwatch.observer/filing/0001213900-25-012213.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.